CytoDyn’s Leronlimab Featured on OneNews in Phil

CytoDyn’s Leronlimab Featured on OneNews in Philippines on May 9

May 07, 2021 6:00am EDT
Drs. Pourhassan, Recknor, Seethamraju and Nicolas will appear in a one-hour segment beginning at 5:00 pm PT / 8:00 pm ET, Sunday, May 9

VANCOUVER, Washington, May 07, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company", a late-stage biotechnology company developing leronlimab (Vyrologix or PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today its drug candidate, leronlimab, will be featured in a one-hour news segment on Sunday, May 9, at 5:00 pm PT / 8:00 pm ET on OneNews in the Philippines. CytoDyn has been supplying leronlimab to the Philippines as a therapeutic treatment for critically ill COVID-19 patients under Compassionate Special Permits (CSPs) authorized by the Philippine FDA.

Appearing in this news program will be Nader Pourhassan, Ph.D, CytoDyn’s President and Chief Executive Officer, Chris Recknor, M.D., CytoDyn’s Chief Operating Officer and Head of Clinical Development, Harish Seethamraju, M.D., Medical Director for the Mount Sinai Lung Transplantation Program in New York, and Richard Nicolas, M.D., Associate Clinical Professor for Cardiothoracic and Vascular Surgery, University of the Philippines, and practicing surgeon, St. Luke’s Medical Center, Philippines.

This news event can be accessed as follows:
Date: Sunday, May 9, 2021
Time: 5:00 pm to 6:00 pm PT / 8:00 pm to 9:00 pm ET

Viewers are encouraged to login 30 minutes prior to the start time

My comments are just my opinions and should NOT be taken as investment advice.